FY2025 · ended Dec 31, 2025 · Revenue $199.12B, +12.5% YoY · Filed Feb 6, 2026
Elevance Health, Inc. (ELV) files with the SEC under industry code 6324, Hospital & Medical Service Plans. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $199.1 billion and net income of $5.7 billion. Free cash flow was $3.2 billion. As of Sep 30, 2026 it held $36.9 billion in cash and investments and $30.8 billion in total debt.
Revenue (TTM)
$201.83B
+3.6% vs year-ago TTM
Net income (TTM)
$5.14B
-7.1% vs year-ago TTM
Operating cash flow (TTM)
$7.60B
+54.6% vs year-ago TTM
Free cash flow (TTM)
$6.51B
+72.9% vs year-ago TTM
EPS (TTM)
$23.43
-3.9% vs year-ago TTM
Dividend per share
$5.92
+15.6% vs prior year
Shares outstanding
220.70M
-2.9% vs prior year
Net cash
$6.15B
as of Sep 30, 2026
Operating margin
2.7%
FY 2026
Company profile
- Industry
- Hospital & Medical Service Plans (SIC 6324)
- Listed as
- ELV (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- IN
- Headquarters
- Indianapolis, IN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1156039
- Former names
- Anthem, Inc. (until Jun 24, 2022); WELLPOINT, INC (until Nov 12, 2014); WELLPOINT INC (until Dec 21, 2009); ANTHEM INC (until Nov 30, 2004)
Other Hospital & Medical Service Plans companies
- Unitedhealth Group Inc UNH
- Cigna Group CI
- Humana Inc HUM
- Centene Corp CNC
- Molina Healthcare, Inc. MOH
- Oscar Health, Inc. OSCR
- Clover Health Investments, Corp. /DE CLOV
- Alignment Healthcare, Inc. ALHC
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $199.1B | $177.0B | $171.3B | $156.6B | $138.6B |
| Operating income | $7.2B | $7.9B | $8.5B | $8.3B | $7.6B |
| Net income | $5.7B | $6.0B | $6.0B | $5.9B | $6.2B |
| Diluted EPS | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 |
| Operating cash flow | $4.3B | $5.8B | $8.1B | $8.4B | $8.4B |
| Free cash flow | $3.2B | $4.6B | $6.8B | $7.2B | $7.3B |
| Total assets | $121.5B | $116.9B | $108.9B | $102.8B | $97.5B |
| Total liabilities | $77.5B | $75.5B | $69.5B | $66.4B | $61.3B |
| Stockholders' equity | $43.9B | $41.3B | $39.3B | $36.2B | $36.1B |
| Cash and investments | $36.5B | $34.5B | $37.0B | $34.1B | $31.8B |
| Total debt | $32.7B | $32.0B | $26.0B | $25.0B | $24.0B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 21, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 21, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 10, 2026 | Sep 10, 2026 |
| 10-Q | Quarterly report | Jul 15, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 15, 2026 | Jul 15, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 10, 2026 | Jun 10, 2026 |
All 1001 Elevance Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.